Anemia
Feature
VEXAS: A novel rheumatologic, hematologic syndrome that’s making waves
News
FDA places clinical hold on sickle cell gene therapy
Conference Coverage
Emotions, worse attention linked to pain-related health care use in SCD
Feature
Landmark sickle cell report targets massive failures, calls for action
Conference Coverage
Survey quantifies COVID-19’s impact on oncology
Oncologists detail how COVID-19 has impacted care, caregivers, continuing medical education, and clinical trials.
From the Journals
Oxidatative stress–related genetic variant tied to stroke risk in sickle cell patients
SOD2 Val16Ala polymorphism may represent a simple and inexpensive alternative for identifying sickle cell patients at risk of stroke.
News
Is anemia due to folate deficiency a myth?
This column includes folate test results from several studies.
News
FDA approves twice-daily formulation of key thalassemia drug
From the Journals
Protective levels of vitamin D achievable in SCD with oral supplementation
Vitamin D3 prophylaxis is a safe practice in sickle cell disease, and it is important to start this prophylactic treatment when the child is an...
Feature
EHA and TIF explore how COVID-19 is affecting thalassemia and SCD patients
Feature
Pandemic strains blood supply for COVID-19 and noninfected patients